LNTH Lantheus Holdings Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: LNTH

Price (delayed)

$99.97

Market cap

$6.53B

P/E Ratio

23.69

Dividend/share

N/A

EPS

$4.22

Enterprise value

$6.5B

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 83

Lantheus is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. Headquartered in Massachusetts with offices in Canada ...

Highlights
The equity has increased by 12% YoY and by 8% from the previous quarter
Lantheus Holdings's EPS has increased by 7% YoY
The price to earnings (P/E) is 48% less than the 5-year quarterly average of 45.9 but 12% more than the last 4 quarters average of 21.1
The company's quick ratio fell by 23% YoY but it rose by 10% QoQ
The company's gross margin fell by 6% YoY
The company's gross profit fell by 3.4% YoY
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Website: http://www.lantheus.com
Peers: CTSO ABT IDXX

Key stats

What are the main financial stats of LNTH

LNTH stock price

How has the Lantheus Holdings stock price performed over time
Intraday
-0.03%
1 week
-0.57%
1 month
0%
1 year
92.03%
YTD
50.22%
QTD
-9.89%

Financial performance

How have Lantheus Holdings's revenue and profit performed over time
Revenue
$1.56B
Gross profit
$936.02M
Operating income
$302.34M
Net income
$275.31M
Gross margin
60.1%
Net margin
17.7%
Lantheus Holdings's operating margin has decreased by 33% YoY but it has increased by 3.2% QoQ
LNTH's operating income is down by 31% YoY but it is up by 4.2% QoQ
The company's gross margin fell by 6% YoY
The company's gross profit fell by 3.4% YoY

Price vs fundamentals

How does LNTH's price correlate with its fundamentals

Growth

What is Lantheus Holdings's growth rate over time

Valuation

What is Lantheus Holdings stock price valuation
LNTH P/E details
P/E
23.69
P/B
4.96
P/S
4.19
EV/EBIT
16.99
EV/EBITDA
13.8
EV/Sales
4.18
The price to earnings (P/E) is 48% less than the 5-year quarterly average of 45.9 but 12% more than the last 4 quarters average of 21.1
Lantheus Holdings's EPS has increased by 7% YoY
The stock's price to book (P/B) is 19% less than its 5-year quarterly average of 6.1 but 18% more than its last 4 quarters average of 4.2
The equity has increased by 12% YoY and by 8% from the previous quarter
The P/S is 31% higher than the last 4 quarters average of 3.2 but 4.8% lower than the 5-year quarterly average of 4.4
The revenue has grown by 2.3% YoY

Efficiency

How efficient is Lantheus Holdings business performance
LNTH's return on assets is down by 10% year-on-year and by 4% since the previous quarter
The return on invested capital has declined by 9% year-on-year
Lantheus Holdings's ROS has decreased by 5% YoY and by 3.1% from the previous quarter
Lantheus Holdings's ROE has decreased by 4.1% from the previous quarter

Dividends

What is LNTH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for LNTH.

Financial health

How did Lantheus Holdings financials performed over time
The total assets is 119% more than the total liabilities
LNTH's current ratio is down by 29% YoY but it is up by 8% from the previous quarter
The company's quick ratio fell by 23% YoY but it rose by 10% QoQ
The company's debt is 56% lower than its equity
The equity has increased by 12% YoY and by 8% from the previous quarter
Lantheus Holdings's debt to equity has decreased by 10% YoY and by 6% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.